Reprod. Sci. 16(2), 178–187 (2009).
Cell Stem Cell 13(5), 535–548 (2013).
Exp. Hematol. 49, 19–24 (2017).
Trends. Biomater. Artif. Organs. 18, 93–100 (2005).
Kuchma, M. D. et al. Comparative analysis of the hematopoietic progenitor cells from placenta, cord blood, and fetal liver, based on their immunophenotype. BioMed. Res. Inter. 2015, 1–16 (2015).
Raju, G. M. K. et al. Colony stimulating activity secreted by human fetal liver cells in comparison to normal adult bone marrow: Role in engraftment after transplantation. Blood 88(1), 258 (1996).
Blood 87, 3500–3507 (1996).
‘In vitro’ maintenance of highly purified, transplantable hematopoietic stem cells. Blood 89, 4337–4340 (1997).
Exp. Hematol. 27, 1418–1427 (1999).
Thymus 10, 131–136 (1987).
Kochupillai, V. et al. Fetal liver infusion in aplastic anemia. Thymus 10(1–2), 95–102 (1987).
Arjmand, B. et al. Co-transplantation of human fetal mesenchymal and hematopoietic stem cells in Type 1 diabetic mice model. Front. Endocrinol. 10, 761 (2019).
Mohamed, A. A. et al. Ex vivo expansion of stem cells: defining optimum conditions using various cytokines. Lab. Hematol. 12, 86–93 (2006).
Piacibello, W. et al. Extensive amplification and self- renewal of human primitive hematopoietic stem cells from cord blood. Blood 89, 2644–2653 (1997).
Defelice, L. et al. Flt3L induces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures. Br. J. Haematol. 106, 133–141 (1999).
Su, R. J. et al. Platelet-derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long-term culture- initiating cells, non-obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells. Br. J. Haematol. 117, 735–746 (2002).
Rappold, I. et al. Gp130-signaling synergizes with FL and TPO for the long-term expansion of cord blood progenitors. Leukemia 13(12), 2036–2048 (1999).
Lazzari, L. et al. Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. Br. J. Haematol. 112, 397–404 (2001).
Fietz, T. et al. Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cells. Bone. Marrow. Transplanta. 11, 1109–1115 (1999).
Kaushansky, K. et al. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J. Clin. Invest. 3, 1683–1687 (1995).
Kawada, H. et al. Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp. Hematol. 27, 904–915 (1999).
Yao, C. L. et al. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133 (+) cells. Stem. Cells. Dev. 15, 70–78 (2006).
Chivu, M. et al. The comparison of different protocols for expansion of umbilical-cord blood hematopoietic stem cells. J. Cell. Mol. Med. 8, 223–231 (2004).
Rollini, P. Long term ex vivo expansion of transplantable human fetal liver hematopoietic stem cells. Blood 103, 1166–1170 (2004).
In vitro and in vivo expansion of hematopoietic stem cells. Oncogene 23, 7223–7232 (2004).
Leukemia 18, 341–347 (2004).
Exp Hematol. 19, 226–238 (1991).
Sui, X. et al. Erythropoietin-independent erythrocyte production: Signals through gp130 and c-kit dramatically promote erythropoiesis from human CD34+ cells. J Exp Med. 183, 837 (1996).
Blood 92, 452–461 (1998).
‘in vitro’ evaluation using semisolid clonal assay system. Stem. Cells. 17, 107–116 (1999).
J. Clin. Invest. 110, 389–394 (2002).
Schuster, J. A. et al. Expansion of hematopoietic stem cells for transplantation: current perspectives. Exp. Hematol. Oncol. 1, 12 (2012).
Jing, L. et al. In Vitro expansion of hematopoietic stem cells by inhibition of both GSK3 and p38 signaling. Stem. Cells. Develop. 28(22), 1–12 (2019).